Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Studies on rodents, pigs, dogs & humans have identified AOD-9604 mechanism where it triggers fat release from the obese fat cells predominantly and works to reduce the accumulation of new fat in fat cells as well as increasing fat burning
On occasion, a second treatment may be required for particularly stubborn areas of skin
5-Amino-1MQs potential lies in breaking this cycle essentially keeping more NAD+ in circulation so cells can function optimally
Testing includes: This level of testing gives you confidence in compound quality and consistency
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
